Known tumour suppressor gene found essential for development, regeneration&stress-response

February 09, 2021

Adult progenitor cells are present in the Drosophila fly as early as its larvae stage. These cells are the only ones that are maintained throughout development and they are responsible for giving rise to adult tissues and organs. Headed by Jordi Casanova (also an IBMB-CSIC researcher), the Development and Morphogenesis in Drosophila lab at IRB Barcelona has identified the headcase (hdc) gene as responsible for the unique characteristics of these adult progenitor cells.

"In our study, mainly using the powerful genetic tools available in Drosophila, we were able to show that this gene regulates the development of the organism, including the stages of metamorphosis, by controlling the growth, proliferation, survival and resistance to stress of adult progenitor cells," Casanova explains.

The headcase gene is homologous to the human HECA gene, and it plays a key role in cancer, acting as a tumour suppressor in both organisms, as it slows down cell cycle.

The link between stress and cancer

Besides identifying headcase as an essential gene for adult progenitor cells, the researchers led by Casanova have also characterised its mechanisms of action. In addition to its participation in hormone-stimulated growth control, this gene is also involved in the stress response and it maintains an equilibrium between these two processes.

"The finding that the headcase gene confers stress protection opens up a new avenue to be explored regarding the role of human HECA as it could also act as a stress protector and its absence may induce stress conditions that favour the initiation and progression of cancer," says Panagiotis Giannios, postdoctoral researcher and first author of the paper.
-end-
This work was supported by the Ministerio de Economía y Competitividad of the Spanish Government and its Severo Ochoa Programme, and by the Generalitat de Catalunya and its CERCA Programme.

Institute for Research in Biomedicine (IRB Barcelona)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.